Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,258
datasets available to search
ShareScore release 0.9.0
Dataset results
1,258 results for “neuroblastoma”
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
ClinicalTrials.gov study NCT07064746. IPD Sharing: YES. Countries: 1. Publications: 28.
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
ClinicalTrials.gov study NCT03860207. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients
ClinicalTrials.gov study NCT02924324. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
ClinicalTrials.gov study NCT01059071. IPD Sharing: Not stated. Countries: 1. Publications: 1.
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
ClinicalTrials.gov study NCT01183884. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
ClinicalTrials.gov study NCT06255210. IPD Sharing: NO. Countries: 1. Publications: 5.
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT03794349. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy Wi
ClinicalTrials.gov study NCT01175356. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Risk Model for Metastasis Detection of Neuroblastoma
ClinicalTrials.gov study NCT06703944. IPD Sharing: YES. Countries: 1. Publications: 0.
Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
ClinicalTrials.gov study NCT00923351. IPD Sharing: NO. Countries: 1. Publications: 3.
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
ClinicalTrials.gov study NCT00026312. IPD Sharing: Not stated. Countries: 5. Publications: 3.
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
ClinicalTrials.gov study NCT03275402. IPD Sharing: NO. Countries: 4. Publications: 2.
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
ClinicalTrials.gov study NCT06803875. IPD Sharing: YES. Countries: 1. Publications: 1.
Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission
ClinicalTrials.gov study NCT02395666. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
ClinicalTrials.gov study NCT07195500. IPD Sharing: YES. Countries: 1. Publications: 10.
Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT01114555. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
ClinicalTrials.gov study NCT00567567. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Data from: Toxicity and magnetometry evaluation of the uptake of core-shell maghemite-silica nanoparticles by neuroblastoma cells
Open the record for dataset details and reuse information.
CDK4/6 inhibitors display a class effect in inducing differentiation of neuroblastoma cells
<p><span>Underlying and Extended data for the manuscript: "</span>CDK4/6 inhibitors display a class effect in inducing differentiation of neuroblastoma cells", Ferguson <em>et al </em>(2024). Includes Underlying Data for Figures 1A-D, Figures 2A-F and Figures 3A-D and the Extended Data: Supplementary Information, data for Figures S1A-C and Movies S1 and S2.</p>
Whole genome RNA-sequencing reveals modulation of genes related to brain disorders by Withania somnifera in human neuroblastoma SK-N-SH cells
<p>Table S1: Human reference genome based differential gene expression; Figure S1: Reactome Pathway (50 μg/mL_3h vs C_3h); Figure S2: Reactome Pathway (50 μg/mL_9h vs C_9h); Figure S3: Reactome pathway (100 μg/mL_3h vs C_3h); Figure S4: GO Dose comparison; Reactome pathway (100 μg/mL_3h vs 50 μg/mL_3h); Figure S5: GO Dose comparison; Reactome pathway (100 μg/mL_9h vs 50 μg/mL_9h); Figure S6: GO Time comparison; Reactome pathway (50 μg/mL_9h vs 50 μg/mL_3h); Figure S7: GO Time comparison; Reactome pathway (100 μg/mL_9h vs 100 μg/mL_3h); Table S2: Disease ontology analysis of 100 μg/mL_3h vs 50 μg/mL_3h WS-treated SK-N-SH cells; Table S3: Disease ontology analysis of 100 μg/mL_9h vs 50 μg/mL_9h WS-treated SK-N-SH cells; Table S4: Disease ontology analysis of 100 μg/mL_9h vs 100 μg/mL_3h WS-treated SK-N-SH cells.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.